Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

janssen_latest_logo_on_sign_closer

FDA approves Janssen’s Xarelto for blood clot prevention

October 15, 2019 Manufacturing and Production, Sales and Marketing FDA, Janssen, US, Xarelto, pharma, thromboembolism

Janssen’s Xarelto (rivaroxaban) has secured FDA approval for the prevention of venous thromboembolism (VTE), or blood clots, in hospitalised acutely …
News
_dsc6538

Medical cannabis: On to greener pastures?

October 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medical cannabis, medicinal cannabis, pharma

In the first of three articles on the topic, Callum McGuinn, Associate and European Patent Attorney at Mewburn Ellis, explores …
Feature

Pfizer reveals strong Phase 3 data for abrocitinib in atopic dermatitis

October 14, 2019 Research and Development, Sales and Marketing Pfizer, abrocitinib, atopic dermatitis, pharma

Pfizer confirmed over the weekend that its oral Janus kinase 1 (JAK1) inhibitor abrocitinib met all of its co-primary and …
News
index_ph001

Daiichi Sankyo show low CV events and bleeding in NVAF patients on Lixiana

October 14, 2019 Sales and Marketing

Daiichi Sankyo have announced one-year follow-up results from an analysis of 12,574 European non-valvular atrial fibrillation (NVAF) patients treated with …
News
shionogi

Shionogi reports positive results for cefiderocol in pneumonia

October 14, 2019 Sales and Marketing

Shionogi has reported positive data from a trial of its investigational antibiotic cefiderocol which is already under regulatory review in …
News
roche__tree

Roche’s Phase 3 Pemphix trial smashes primary endpoint for pemphigus vulgaris

October 14, 2019 Research and Development, Sales and Marketing MabThera, Rituxan, Roche, pharma

Roche has revealed new Phase 3 data demonstrating that its MabThera/Rituxan (rituximab) therapy Pemphix met its primary endpoint in the …
News

Three focus areas to accelerate breakthrough drugs to market

October 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing veeva

The number of clinical trials taking place each year continues to rise. In fact, in 2018, the FDA approved a …
Feature
Thought Leadership
jim_greenwood

Biotechnology Innovation Organization Chief to step down after US 2020 elections

October 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotechnology Innovation Organization, US, biotech, pharma

The Biotechnology Innovation Organization (BIO), the largest trade body representing the world’s biotechnology industry, has revealed that its President and …
News
top_10_photo

Top Ten most popular articles on Pharmafile.com this week

October 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s the end of the week and time for a rundown of our top most popular articles on Pharmafile these …
News

Clovis Oncology’s Rubraca now available via the Cancer Drugs Fund for ovarian, peritoneal, fallopian tube cancer

October 11, 2019 Medical Communications, Sales and Marketing Cancer, Clovis Oncology, NHS, NICE, Rubraca, fallopian tube cancer, ovarian cancer, peritoneal cancer, pharma

NICE has announced it has made an about-face on its earlier ruling for Clovis Oncology’s Rubraca (rucaparib), revealing that the …
News

NICE recommends pentosan polysulfate sodium for NHS treatment of bladder pain syndrome

October 10, 2019 Sales and Marketing NHS, NICE, bladder pain syndrome, pentosan polysulfate sodium

NICE has chosen to recommend pentosan polysulfate sodium, it has emerged, for use on the NHS in the treatment of …
News
20120905_ucb_02

UCB Pharma to acquire Ra Pharmaceuticals in deal valued at $2.1bn

October 10, 2019 Sales and Marketing

UCB has agreed to acquire US-based Ra Pharmaceuticals for $2.1 billion in a deal that will enable the Belgian drug …
News
lung_ambition_alliance

The Lung Ambition Alliance: Stronger together

October 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Lung Ambition Alliance, lung cancer, pharma

Following our piece by AstraZeneca’s Patrick Connor introducing the Lung Ambition Alliance, a new cross-functional collaboration which aims to double …
Feature

FDA approves Pfenex’s osteoarthritis drug for patients at high risk of fracture

October 9, 2019 Research and Development, Sales and Marketing FDA, Pfenex, osteoporosis, pharma

The FDA has awarded US approval to Pfenex’s drug PF708, it has emerged, as a treatment for osteoporosis in certain …
News
gilead-sciences

Gilead’s CAR-T therapy Yescarta now available via NHS Scotland for two forms of B-cell lymphoma

October 8, 2019 Manufacturing and Production, Sales and Marketing CAR T, CAR-T, NHS, Scotland, Scottish Medicines Consortium, pharma

News has broken that the Scottish Medicines Consortium (SMC) has chosen to approve the use of Gilead’s chimeric antigen receptor …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025